Search results
A longtime Apple skeptic warms up to the stock. Why we're not cheering the call just yet
CNBC· 5 days agoA longtime Apple skeptic upgraded the iPhone maker, sending the struggling Club stock higher in...
We are making another buy of this retailer ahead of the coming rebound in PCs
CNBC· 4 days agoFollowing the trade, Jim Cramer's Charitable Trust will own 1,000 shares of BBY, increasing its...
Cramer: Why Apple's Vision Pro could contribute to earnings sooner than expected
CNBC· 1 day agoOne big question has hung over the Vision Pro since Apple launched the powerful mixed-reality...
TFI International Inc. (NYSE:TFII) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoTFI International Inc. (NYSE:TFII) Q1 2024 Earnings Call Transcript April 26, 2024 TFI International...
Marin Software Incorporated (NASDAQ:MRIN) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoMarin Software Incorporated (NASDAQ:MRIN) Q1 2024 Earnings Call Transcript May 2, 2024 Marin...
Roku, Inc. (NASDAQ:ROKU) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 4 days agoRoku, Inc. (NASDAQ:ROKU) Q1 2024 Earnings Call Transcript April 25, 2024 Roku, Inc. beats earnings...
Global Industrial Company (NYSE:GIC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoGlobal Industrial Company (NYSE:GIC) Q1 2024 Earnings Call Transcript April 30, 2024 Global...
Starbucks gets a price target cut after a brutal quarterly miss and light guidance
CNBC· 4 days agoStarbucks shares plummeted Tuesday evening by roughly 11.5% after the coffee giant delivered a much...
SunCoke Energy, Inc. (NYSE:SXC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoSunCoke Energy, Inc. (NYSE:SXC) Q1 2024 Earnings Call Transcript May 1, 2024 SunCoke Energy, Inc....
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 4 days agoEli Lilly 's raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly ...